During a monthly internal quality improvement (QI) meeting, you review several patient care reports (PCRs) that include patient name, age, and sex, discussing the treatment that was provided. By this approach to the QI process, you:

• A. Acted appropriately but must have each EMT sign a waiver stating that he or she will not discuss the cases with others.
• B. Are in violation of HIPAA because you did not remove the PHI from the PCR beforehand.
• C. Violated the patient's privacy because you should have discussed the information only with the EMTs involved.
• D. Adequately safeguarded the patient's PHI because the cases were discussed internally.

Answer: (B)

In HIPAA, protecting patient privacy means only sharing identifying health information with people who have a legitimate need to know and doing so in a way that minimizes exposure. Reviewing patient care reports that include a patient’s name, age, and sex in a monthly internal quality improvement meeting means you're disclosing identifiable health information to attendees who may not need to know all those details. Unless the PHI is removed or de-identified (or access is strictly limited to those with a legitimate need to know), this exposure violates HIPAA. The appropriate approach is to redaction or use de-identified data for QA discussions, while still allowing the organization to conduct quality improvement within the privacy rule’s minimum-necessary framework. HIPAA does allow internal reviews for healthcare operations, but only with the minimum necessary information shared; leaving identifiable information in the PCRs discussed at the meeting does not meet that standard.